Get the Stockscreener App
7.805
1.15%
0.085
Ginkgo Bioworks Holdings Inc stock is traded at $7.805, with a volume of 507.43K.
It is up +1.15% in the last 24 hours and up +14.84% over the past month.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
See More
Previous Close:
$7.72
Open:
$7.78
24h Volume:
507.43K
Relative Volume:
0.45
Market Cap:
$483.32M
Revenue:
$170.16M
Net Income/Loss:
$-312.76M
P/E Ratio:
-1.3732
EPS:
-5.6837
Net Cash Flow:
$-178.72M
1W Performance:
+13.50%
1M Performance:
+14.84%
6M Performance:
-50.67%
1Y Performance:
-5.35%
1-Day Range:
$7.66
$8.0172
1-Week Range:
$6.165
$8.0172
52-Week Range:
$5.37
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Name
Ginkgo Bioworks Holdings Inc
Sector
Industry
Phone
(877) 442-5362
Address
27 DRYDOCK AVENUE, BOSTON
Compare DNA vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
7.805 | 478.06M | 170.16M | -312.76M | -178.72M | -5.6837 |
VRTX
Vertex Pharmaceuticals Inc
|
442.41 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
748.47 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
842.97 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
334.65 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
317.28 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-24 | Downgrade | BTIG Research | Neutral → Sell |
| May-10-24 | Downgrade | William Blair | Mkt Perform → Underperform |
| Nov-14-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-09-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-02-23 | Downgrade | Goldman | Neutral → Sell |
| May-11-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-29-22 | Initiated | Berenberg | Buy |
| Oct-04-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Feb-23-22 | Initiated | Goldman | Neutral |
| Feb-01-22 | Initiated | BofA Securities | Neutral |
| Jan-28-22 | Initiated | BofA Securities | Buy |
| Jan-07-22 | Initiated | BTIG Research | Buy |
| Nov-29-21 | Initiated | Jefferies | Buy |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Oct-12-21 | Initiated | William Blair | Outperform |
| Sep-20-21 | Initiated | HSBC Securities | Buy |
View All
Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News
DNA (NYSE: DNA) Rule 144 shows insider resale notices totaling tens of thousands of shares - Stock Titan
Ginkgo Bioworks CFO Coen sells $212k in shares By Investing.com - Investing.com India
Ginkgo Bioworks CFO Coen sells $212k in shares - Investing.com
Ginkgo Bioworks (NYSE: DNA) CFO nets PSU shares, sells stock for taxes - Stock Titan
Ginkgo Bioworks (DNA) major shareholder sells $802k in stock By Investing.com - Investing.com India
PSU vesting drives tax share sale for Ginkgo Bioworks (DNA) holder - Stock Titan
Reshma Shetty of Ginkgo Bioworks (DNA) sells shares to cover tax after PSU vesting - Stock Titan
DNA (NYSE: DNA) files Form 144: 33,171 Class A shares tied to vesting - Stock Titan
Proposed Class A sale by DNA (NYSE: DNA) — Form 144 lists 40,893 shares - Stock Titan
Ginkgo Bioworks Announces Date of Second Quarter 2024 Results Pr - GuruFocus
Aug Reactions: Is Ginkgo Bioworks Holdings Inc a strong candidate for buy and hold2026 Update & Stepwise Trade Signal Guides - baoquankhu1.vn
Trading Action: Is Ginkgo Bioworks Holdings Inc part of any major index2026 Closing Moves & Advanced Technical Signal Analysis - baoquankhu1.vn
DNA SEC FilingsGinkgo Bioworks Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Chart Watch: Can Ginkgo Bioworks Holdings Inc navigate macro headwindsPortfolio Performance Summary & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Ginkgo Bioworks CEO sells $1.37 million in shares By Investing.com - Investing.com South Africa
Ginkgo Bioworks CEO sells $1.37 million in shares - Investing.com
Ginkgo Bioworks 10% owner Canton sells $175k in DNA stock - Investing.com
Ginkgo Bioworks director Shetty sells $175k in shares - Investing.com
Ginkgo Bioworks director Shetty sells $175k in shares By Investing.com - Investing.com India
Tax-driven share sales follow PSU vesting at Ginkgo Bioworks (DNA) - Stock Titan
Tax-driven stock sales by major Ginkgo Bioworks (DNA) holder Barry Canton - Stock Titan
Ginkgo Bioworks (NYSE: DNA) insider vests PSUs, sells shares for taxes - Stock Titan
Director sales at DNA (NYSE: DNA) — 13,155 and 13,116 Class A shares - Stock Titan
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
DNA (NYSE: DNA) Form 144: 13,116 Class A shares proposed sale - Stock Titan
Jason Kelly to sell 109,767 Class A shares (NYSE: DNA) under Form 144 - Stock Titan
US Market Recap: Can Ginkgo Bioworks Holdings Inc maintain sales growthAnalyst Upgrade & Weekly Breakout Stock Alerts - baoquankhu1.vn
ProQR (PRQR) Partners with Ginkgo Bioworks to Boost AI-Driven Dr - GuruFocus
ProQR forms advisory board, partnership with Ginkgo as part of AI strategy - MSN
ProQR Forms AI Advisory Board and Partners with Ginkgo Bioworks - Intellectia AI
[144] Ginkgo Bioworks Holdings, Inc. SEC Filing - Stock Titan
ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event - GlobeNewswire Inc.
ProQR in pact with Ginkgo as part of AI strategy (PRQR:NASDAQ) - Seeking Alpha
ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board - Yahoo Finance
Aug Shorts: Is Ginkgo Bioworks Holdings Inc attractive for institutional investors2026 Analyst Calls & Weekly Setup with High ROI Potential - baoquankhu1.vn
Ginkgo Bioworks Divests Biosecurity Segment to Tower Biosecurity in Strategic Shift – Financial Impact and Pro Forma Results - Minichart
Ginkgo Bioworks Divests Biosecurity Unit, Refocuses Core Operations - TipRanks
Ginkgo Bioworks (DNA) divests Biosecurity segment, retains 20% Tower stake - Stock Titan
Institution Moves: What are Ginkgo Bioworks Holdings Incs recent SEC filings showingQuarterly Investment Review & Growth-Oriented Investment Plans - baoquankhu1.vn
Weekly Recap: What are Ginkgo Bioworks Holdings Incs recent SEC filings showingWatch List & Risk Managed Trade Strategies - baoquankhu1.vn
Quarterly Risk: Is Ginkgo Bioworks Holdings Inc attractive for institutional investors2026 Trade Ideas & Community Verified Watchlist Alerts - baoquankhu1.vn
(DNA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
8-K: Current report - Moomoo
Aug Shorts: Why is Ginkgo Bioworks Holdings Inc stock going up2026 Trends & Weekly Top Performers Watchlists - baoquankhu1.vn
Market Leaders: What are Ginkgo Bioworks Holdings Incs recent SEC filings showingInsider Buying & Consistent Income Trade Ideas - baoquankhu1.vn
DNA Stock Price, Quote & Chart | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
Is Ginkgo Bioworks Holdings Inc stock a value trap2026 Spike Watch & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Investment Review: Is Ginkgo Bioworks Holdings Inc a strong candidate for buy and hold2026 Volume Leaders & Verified Swing Trading Watchlists - baoquankhu1.vn
Performance Recap: Is Ginkgo Bioworks Holdings Inc a cyclical or defensive stockPortfolio Return Summary & Entry and Exit Point Strategies - baoquankhu1.vn
Wall Street Zen Downgrades Ginkgo Bioworks (NYSE:DNA) to Sell - MarketBeat
Pullback Watch: Is Ginkgo Bioworks Holdings Inc a strong candidate for buy and holdGold Moves & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Ginkgo Bioworks Holdings Inc Stock (DNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.68%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):